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Abstract
Objective:  To  investigate  the  association  between  serum  uric  acid  levels  and  insulin  resistance
in children  and  adolescents  with  obesity.
Methods:  Cross-sectional  study  with  245  children  and  adolescents  (134  obese  and  111  controls),
aged 8--18  years.  The  anthropometric  variables  (weight,  height  and  waist  circumference),  blood
pressure and  biochemical  parameters  were  collected.  The  clinical  characteristics  of  the  groups
were analyzed  by  t-test  or  chi-square  test.  To  evaluate  the  association  between  uric  acid  levels
and insulin  resistance  the  Pearson’s  test  and  logistic  regression  were  applied.
Results:  The  prevalence  of  insulin  resistance  was  26.9%.  The  anthropometric  variables,  systolic
and diastolic  blood  pressure  and  biochemical  variables  were  signiﬁcantly  higher  in  the  obese
group (p<0.001),  except  for  the  high-density-lipoprotein  cholesterol.  There  was  a  positive  and
signiﬁcant correlation  between  anthropometric  variables  and  uric  acid  with  HOMA-IR  in  the
obese and  in  the  control  groups,  which  was  higher  in  the  obese  group  and  in  the  total  sample.
The logistic  regression  model  that  included  age,  gender  and  obesity,  showed  an  odds  ratio  of
uric acid  as  a  variable  associated  with  insulin  resistance  of  1.91  (95%CI  1.40--2.62;  p<−0.001).
Conclusions:  The  increase  in  serum  uric  acid  showed  a  positive  statistical  correlation  with
insulin resistance  and  it  is  associated  with  and  increased  risk  of  insulin  resistance  in  obese
children  and  adolescents.
© 2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-  license  (https://creativecommons.org/licenses/by/4.0/).
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PALAVRAS-CHAVE
Obesidade  pediátrica;
Resistência  à  insulina;
Ácido  úrico
O  papel  do  ácido  úrico  na  resistência  insulínica  em  crianc¸as e  adolescentes  com
obesidade
Resumo
Objetivo:  Investigar  a  associac¸ão  entre  os  níveis  séricos  de  ácido  úrico  e  resistência  insulínica
em crianc¸as  e  adolescentes  com  obesidade.
Métodos:  Estudo  transversal,  com  245  crianc¸as  e  adolescentes  (134  obesos  e  111  controles),
com idade  entre  oito  e  18  anos.  Foram  coletadas  variáveis  antropométricas  (peso,  estatura  e
circunferência  abdominal),  pressão  arterial  e  parâmetros  bioquímicos.  As  características  clíni-
cas dos  grupos  foram  analisadas  pelo  teste  t  ou  pelo  qui-quadrado.  Para  avaliar  a  associac¸ão
entre  os  níveis  de  ácido  úrico  e  a  resistência  insulínica  utilizou-se  o  teste  de  Pearson  e  regressão
logística,  sendo  a  resistência  insulínica  a  variável  dependente  no  modelo  de  regressão.
Resultados:  A  prevalência  de  resistência  insulínica  foi  de  26,9%.  As  variáveis  antropométricas,
a pressão  arterial  sistólica  e  diastólica  e  as  variáveis  bioquímicas  foram  maiores  no  grupo  obeso
(p<0,001),  exceto  o  colesterol  de  alta  densidade.  Foi  observada  correlac¸ão  positiva  e  signiﬁca-
tiva entre  as  variáveis  antropométricas  e  o  ácido  úrico  com  o  HOMA-IR  no  grupo  obeso  e  no
controle, sendo  esta  maior  no  grupo  obeso  e  na  amostra  total.  No  modelo  de  regressão  logís-
tica que  incluiu  idade,  sexo  e  obesidade,  a  Odds  Ratio  do  ácido  úrico  como  fator  associado  à
resistência  insulínica  foi  1,91  (IC95%  1,40--2,62;  p<0,001).
Conclusões:  Observa-se  que  o  aumento  no  nível  sérico  de  ácido  úrico  apresenta  correlac¸ão
estatística  positiva  com  a  resistência  insulínica  e  está  associado  à  elevac¸ão  no  risco  da  mesma,
em crianc¸as  e  adolescentes  obesos.
© 2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este  é  um  artigo
Open Access  sob  a  licença  CC  BY  (https://creativecommons.org/licenses/by/4.0/deed.pt).
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ric  acid  is  the  end  product  of  purine  metabolism,  produced
y  the  liver  and  excreted  by  the  kidneys,1 with  recognized
ntioxidant  action  when  its  blood  levels  are  within  physi-
logical  limits.2 However,  the  increase  in  its  serum  levels,
alled  hyperuricemia,  is  an  independent  risk  factor  for  car-
iovascular  disease  and  also  has  a  role  in  the  development
f  metabolic  diseases.3--5 Moreover,  recent  prospective  stud-
es  with  representative  samples  indicate  hyperuricemia  as
 predictor  for  the  development  of  insulin  resistance  and
ype  2  diabetes  mellitus.4,5 Krishnan  et  al.5 showed  that
yperuricemia  increases  by  1.87-fold  the  chance  of  devel-
ping  type  2  diabetes  mellitus  and  1.36-fold  the  chance  of
eveloping  insulin  resistance  after  15  years  of  follow-up.
One  of  the  pathological  conditions  associated  with  hype-
uricemia  is  obesity.6,7 Obese  individuals  have  lower  renal
xcretion,  and  may  also  have  increased  production  of
ric  acid.8 In  children  and  adolescents,  studies  indicate
hat  the  association  between  hyperuricemia  and  obe-
ity  is  positive6 and  it  is  associated  with  cardiometabolic
omplications,  such  as  hypertension,  atherosclerosis  and
etabolic  syndrome.9--12 Yoo  et  al.13 studied  the  prevalence
f  insulin  resistance  and  metabolic  syndrome  in  patients
ith  gout,  which  is  a  metabolic  disease  characterized  by
yperuricemia  and  deposition  of  monosodium  urate  crystals
n  the  joints  and  tissues.  The  authors  concluded  that  these
atients  have  a  higher  prevalence  of  insulin  resistance  and
etabolic  syndrome  when  compared  to  their  healthy  peers,
nd  that  hyperuricemia  in  association  with  insulin  resistance
ay  be  caused  by  abdominal  obesity.13
w
e
a
eIn  this  context,  in  which  hyperuricemia  has  been  identi-
ed  as  another  link  between  obesity  and  insulin  resistance,
tudies  in  the  pediatric  population  are  scarce.  Therefore,
he  aim  of  this  study  was  to  investigate  the  association
etween  serum  uric  acid  levels  and  insulin  resistance  in
bese  children  and  adolescents.
ethod
ross-sectional  study  with  a quantitative  approach,  part  of
 project  entitled  ‘‘Association  of  genetic  polymorphisms  of
ardiovascular  relevance  with  systemic  arterial  hyperten-
ion  and  obesity  in  childhood  and  adolescence’’,  approved
y  the  Institutional  Review  Board  of  Universidade  Federal
e  Juiz  de  Fora,  process  number  1942.001.2010.  All  those
nvolved  in  the  research,  parents  or  guardians  and  children
nd  adolescents  were  informed  of  the  study  objectives  and
rocedures,  and  those  who  agreed  to  participate  in  the  study
igned  the  Informed  Consent  Form.
The  study  population  consisted  of  children  and  adoles-
ents  treated  at  the  outpatient  clinic  of  Instituto  da  Crianc¸a
 do  Adolescente  de  Juiz  de  Fora  and  at  the  Children’s
ndocrinology  Outpatient  Clinic  of  Núcleo  Interdisciplinar
e  Estudos  e  Pesquisa  em  Nefrologia  --  NIEPEN,  of  Uni-
ersidade  Federal  de  Juiz  de  Fora,  Juiz  de  Fora,  Minas
erais  State,  Brazil.  Convenience  sampling  was  carried  out,
hich  included  134  obese  children  and  adolescents  in  the
xperimental  group  and  111  normal-weight  children  and
dolescents.  The  non-inclusion  criteria  were  chronic  dis-
ases,  endocrine  disorders,  use  of  drugs,  signs  of  acute
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Table  1  Clinical  characteristics  of  the  study  groups.
Variables  Control  (n=111)  Obese  (n=134)  p
Gender  (%  F)  66  48  0.005
Age (years) 12.5±2.5 11.2±2.3  <0.001
BMI (kg/m2)  18.8±2.6  27.0±4.5  <0.001
WC (cm)  68.7±8.7  90.2±12.8  <0.001
SBP (mmHg)  107.2±10.7  117.9±14.5  <0.001
DBP (mmHg)  66.6±9.2  74.5±9.5  <0.001
Total cholesterol  (mg/dL)  134.2±28.6  150.3±40.7  0.001
HDL-c (mg/dL)  44.1±9.7  38.5±9.7  <0.001
LDL-c (mg/dL)  73.7±21.1  91.8±33.1  <0.001
Triglycerides  (mg/dL) 74.1±27.1 92.0±44.9 <0.001
Glucose  (mg/dL) 82.3±10.5 86.6±9.4 0.001
Insulin  (UI/mL)  9.4±4.0  13.8±6.2  <0.001
HOMA-IR 1.93±0.92  2.98±1.49  <0.001
Uric acid  (mg/dL)  3.50±1.12  4.47±1.13  <0.001
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tF, female; M, male; BMI, body mass index; WC, waist circumfere
high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, h
infection  and  pregnancy.  All  children  and  adolescents  under-
went  physical  examination.
Weight  and  height  were  measured  while  participants
were  wearing  light  clothing  and  no  shoes.  Height  was  mea-
sured  with  a  0.1  cm-accuracy  using  a  wall  stadiometer.  Body
weight  was  measured  with  a  digital  scale  with  a  0.1  kg-
accuracy.  Obesity  was  deﬁned  as  body  mass  index  (BMI)
above  the  95th  percentile  for  age  and  gender.14 Waist  cir-
cumference  (WC)  was  measured  using  an  inelastic  tape  at
midpoint  between  the  last  rib  and  the  upper  border  of  the
iliac  crest.15 Blood  pressure  was  measured  by  auscultation,
and  the  appropriate  cuff  size  was  considered.  After  resting
for  10  min  in  a  quiet  environment,  blood  pressure  measure-
ment  was  taken.16 After  the  physical  examination,  blood
collection  was  performed  by  venipuncture  in  the  morning,
after  12  h  of  fasting.  The  blood  was  immediately  centrifuged
at  room  temperature,  and  plasma  and  serum  samples  were
stored  at  −70 ◦C  until  they  were  analyzed.
The  levels  of  glucose,  uric  acid  and  the  lipid  parameters
(total  cholesterol,  triglycerides  and  high-density-lipoprotein
cholesterol)  were  measured  in  serum,  with  routine  enzy-
matic  methods,  using  commercial  kits  (Labtest  Diagnostics,
AS,  Lagoa  Santa,  Brazil).  The  level  of  low-density-
lipoprotein  cholesterol  was  estimated  using  the  Friedewald
formula.17 The  insulin  level  was  determined  by  serum
enzyme  immunoassay  kit  (Genese  Produtos  Diagnósticos,
São  Paulo,  Brazil).  The  estimate  of  insulin  resistance  was
obtained  through  the  Homeostasis  Model  Assessment  for
Insulin  Resistance  (HOMA-IR),  which  is  the  product  of  fas-
ting  insulin  (U/mL)  and  fasting  plasma  glucose  (mmol/L)
divided  by  22.5.  Insulin  resistance  is  deﬁned  when  the
HOMA-IR  value  was  greater  than  or  equal  to  3.16.18
Data  are  shown  as  mean  ±  standard  deviation.  The  clini-
cal  characteristics  of  the  groups  were  analyzed  using  the  t  or
Chi-square  tests.  To  evaluate  the  association  between  age,
BMI,  WC,  systolic  blood  pressure,  diastolic  blood  pressure,
HDL  and  uric  acid  with  HOMA-IR,  we  used  Pearson’s  corre-
lation  test.  A  logistic  regression  model  was  also  produced
to  measure  the  association  between  uric  acid  levels  (inde-
pendent  variable)  and  insulin  resistance  (binary  dependent
r
e
a
pSBP, systolic blood pressure; DBP, diastolic blood pressure; HDL,
ostatic model assessment for insulin resistance.
ariable).  Other  independent  variables  and  potentially  con-
ounding  variables  (age,  gender  and  obesity)  were  included
n  the  regression  model  in  order  to  control  their  possible
ffect  on  insulin  resistance.  The  selected  independent  varia-
les  were  included  in  the  model  because  of  the  known
ssociation  between  them  and  insulin  resistance.6 The  sig-
iﬁcance  level  was  set  at  5%  (p<0.05)  for  all  tests,  and  the
tatistical  software  used  was  SPSS  version  15.0.
esults
e  evaluated  245  children  and  adolescents  (55.9%  females)
nd  the  prevalence  of  insulin  resistance  was  26.9%.  The
linical  characteristics  of  the  assessed  groups  are  shown  in
able  1. As  expected,  the  obese  group  had  higher  BMI  and
C  values  than  the  control  group  (p<0.001).  The  systolic
nd  diastolic  blood  pressures  were  higher  in  the  obese  group
hen  compared  to  the  control  group  (p<0.001).  In  addition,
ll  the  biochemical  characteristics,  total  cholesterol,  LDL,
riglycerides,  glucose,  uric  acid,  insulin  and  HOMA-IR  had
igher  levels  in  the  obese  group,  except  for  the  HDL,  which
as  lower  in  the  obese  group  when  compared  to  the  control
roup  (p<0.001).
Table  2  shows  the  results  of  the  correlation  analysis
etween  the  variables  age,  BMI,  WC,  systolic  blood  pressure,
iastolic  blood  pressure,  HDL  and  uric  acid  with  HOMA-
R  in  obese,  control  groups  and  in  both  groups.  In  the
bese  group  there  was  a  positive  and  signiﬁcant  correlation
etween  most  of  the  variables  with  the  HOMA-IR,  except
or  age,  which  was  not  correlated  with  HOMA-IR,  and  HDL,
hich  showed  a  negative  correlation.  In  the  control  group,
here  was  a  positive  and  signiﬁcant  correlation  between  BMI
nd  HOMA-IR  and  uric  acid  and  HOMA-IR.  When  analyzing
he  total  sample,  there  is  a positive  and  signiﬁcant  cor-
elation  between  most  of  the  variables  and  the  HOMA-IR,
xcept  for  age,  which  was  not  correlated  with  HOMA-IR,
nd  HDL,  which  showed  a  negative  correlation.  The  anthro-
ometric  variables  (BMI  and  waist  circumference)  and  uric
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Table  2  Correlation  between  HOMA-IR  and  the  variables  analyzed  by  groups.
Variables  Obese  group  Control  group  Total  sample
HOMA-IR  HOMA-IR  HOMA-IR
r  p  r  p  r  p
Age  (years)  0.065  0.458  0.036  0.708  −0.075  0.241
BMI (kg/m2)  0.355  <0.001  0.239  0.011  0.447  <0.001
SBP (mmHg) 0.261 0.003 0.128  0.197  0.292  <0.001
DBP (mmHg) 0.261 0.003 0.115 0.224  0.256  <0.001
WC (cm) 0.364 <0.001 0.119 0.222 0.437 <0.001
HDL  (mg/dL)  −0.118  0.029  −0.027  0.780  −0.258  <0.001
Uric acid  (mg/dL)  0.282  0.001  0.214  0.024  0.380  <0.001
 pres
a
r
e
i
b
a
a
o
v
t
d
a
(
c
9
D
T
s
a
d
t
e
r
g
H
o
r
a
o
w
d
a
m
w
s
t
d
d
c
i
r
u
i
d
i
s
e
n
n
a
a
a
h
p
b
s
a
d
l
s
t
p
c
i
w
o
a
w
p
w
s
t
c
oBMI, body mass index; WC, waist circumference; SBP, systolic blood
HOMA-IR, homeostatic model assessment for insulin resistance.
cid  showed  the  best  correlations  with  HOMA-IR  (r=0.447,
=0.437  and  r=380;  p<0.001  respectively).
The  association  of  insulin  resistance  with  uric  acid  lev-
ls  was  also  assessed  in  a  logistic  regression  model,  which
ncluded  age,  gender  and  obesity  as  independent  varia-
les.  The  logistic  regression  model  produced  to  measure  the
ssociation  between  uric  acid  levels  (independent  variable)
nd  insulin  resistance  (binary  dependent  variable)  included
ther  independent  variables  and  potentially  confounding
ariables  (age,  gender  and  obesity),  included  in  the  model
o  control  their  possible  effects  on  insulin  resistance.  The
ependent  variable  (insulin  resistance)  was  dichotomized
ccording  to  the  HOMA-IR  cutoff  point  (3.16).  The  odds  ratio
OR)  of  uric  acid  was  1.91  (95%CI:  1.40--2.62;  p<0.001),  indi-
ating  that  the  increase  of  one  uric  acid  unit  increases  by
1%  the  likelihood  of  insulin  resistance.
iscussion
he  main  ﬁnding  of  this  study  was  the  association  between
erum  uric  acid  levels  and  insulin  resistance  in  children  and
dolescents,  even  after  adjusting  for  age,  obesity  and  gen-
er.  After  adjusting  for  these  variables,  it  was  observed
hat,  for  every  increase  of  1  mg/dL  in  serum  uric  acid  lev-
ls,  there  would  be  a  91%  increase  in  the  chance  of  insulin
esistance.  Even  when  analyzing  the  obese  and  the  control
roups  alone,  uric  acid  and  BMI  showed  a  correlation  with
OMA-IR  (Table  2).
This  ﬁnding  is  in  agreement  with  other  authors,  who  also
bserved  an  association  between  uric  acid  levels  and  insulin
esistance  in  studies  involving  children  in  a  more  limited
ge  range.6,9 Gil-Campos  et  al.6 found  that  in  prepubertal
bese  children,  the  uric  acid  levels  were  signiﬁcantly  higher
hen  compared  to  the  control  group,  after  adjusting  for  gen-
er,  age  and  BMI  associated  with  insulin  resistance.  These
uthors  propose  that  the  increase  in  serum  levels  of  uric  acid
ay  be  an  indicator  of  early  metabolic  changes  associated
ith  other  insulin  resistance  characteristics.  In  our  study,
tatistical  difference  was  observed  regarding  age  between
he  assessed  groups,  which  was  only  half  of  the  standard
eviation  (50%),  and  with  normal  distribution.  Thus,  this
ifference  was  not  considered  to  be  clinically  signiﬁcant,
onsidering  the  degree  of  dispersion  of  this  variable.
w
s
x
asure; DBP, diastolic blood pressure; HDL, high-density lipoprotein;
In  fact,  in  the  adult  population,  recent  prospective  stud-
es  indicate  that  hyperuricemia  is  a  predictor  of  insulin
esistance  and  type  2  diabetes  mellitus.4,5,19 After  a  follow-
p  of  15  years,  Krishnan  et  al.5 showed  that  hyperuricemia
ncreases  by  1.87-fold  the  chance  of  developing  type  2
iabetes  mellitus  and  by  1.36-fold  the  chance  of  develop-
ng  insulin  resistance.  In  a  meta-analysis,  Kodama  et  al.19
howed  an  increase  of  17%  in  the  risk  of  type  2 diabetes  for
very  increase  of  1  mg/dL  in  serum  uric  acid.
Although  the  physiopathological  mechanisms  of  the  con-
ection  between  hyperuricemia  and  insulin  resistance  are
ot  yet  clearly  established,  hyperuricemia  is  often  seen
s  the  result  of  the  reduction  in  renal  excretion  of  uric
cid  under  the  action  of  hyperinsulinemia.1,20 However,  the
forementioned  studies  oppose  this  idea,  as  they  show  that
yperuricemia  precedes  insulin  resistance.4,5,19
In  this  study,  it  was  also  not  possible  to  answer  what  the
hysiopathological  mechanisms  of  serum  uric  acid  contri-
ution  on  insulin  resistance  are  in  obesity,  but  our  work  is
upported  by  previous  results  of  studies  with  animal  models
nd  clinical  trials,  so  that  some  speculations  can  be  made.
Obesity  is  considered  a  signiﬁcant  risk  factor  for  the
evelopment  of  insulin  resistance  and  type  2  diabetes  mel-
itus,  as  in  obese  individuals  the  adipose  tissue  releases
ubstances  involved  in  the  development  of  insulin  resis-
ance,  such  as  non-esteriﬁed  fatty  acids,  hormones  and
roinﬂammatory  cytokines.21,22 Adipose  tissue  has  the
apacity  to  secrete  cytokines  and  growth  factors  that  partic-
pate  in  many  metabolic  processes.  Some  of  these  cytokines,
ith  pro-inﬂammatory  characteristics  that  are  increased  in
besity,  are  directly  associated  with  insulin  resistance,  such
s  leptin,  TNF- and  visfatin,  while  adiponectin,  a  cytokine
ith  anti-inﬂammatory  characteristics,  is  reduced  in  the
resence  of  obesity  and  is  described  as  inversely  associated
ith  insulin  resistance.21
Another  ﬁnding  of  our  study  was  that  the  obese  group  had
tatistically  higher  serum  uric  acid  levels  when  compared  to
he  control  group  (4.47±1.13  vs.  3.50±1.12,  p<0.001).  This
haracteristic  can  be  attributed  to  the  following  factors:  (1)
bese  individuals  have  reduced  renal  clearance  of  uric  acid,
hich  can  result  in  higher  serum  levels23;  (2)  adipose  tissue,
imilar  to  the  liver  and  intestine,  has  abundant  activity  of
anthine  oxidase  (enzyme  responsible  for  catalyzing  purines
nd  uric  acid);  and  (3)  obesity  is  associated  with  elevated
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activity  of  xanthine  oxidase  and  increased  production  of  uric
acid  by  adipose  tissue.8
One  of  the  possible  links  between  hyperuricemia  and
insulin  resistance  seems  to  be  endothelial  dysfunction.
Hyperuricemia  induction  in  animals  resulted  in  reduced
nitric  oxide  bioavailability,  vasoconstriction  and  the  devel-
opment  of  microvascular  disease24 and,  according  to  Park
et  al.,25 uric  acid  is  responsible  for  attenuating  the  pro-
duction  of  nitric  oxide  by  reducing  the  interaction  between
eNOS  (endothelial  nitric  oxide  synthase  enzyme),  and
calmodulin.  In  fact,  clinical  studies  have  shown  that  ele-
vated  levels  of  uric  acid  are  associated  with  impaired
vascular  function  in  children  and  adolescents.12,26 Thus,
the  hyperuricemia-mediated  endothelial  dysfunction  could
result  in  lower  insulin  uptake  by  reduced  blood  ﬂow  in
peripheral  tissues  (less  nitric  oxide  supply).1
In  addition  to  interfering  with  nitric  oxide  production,
uric  acid  may  also  be  responsible  for  its  degradation.
Although,  at  physiological  concentrations,  uric  acid  has
antioxidant  effects,  thus  being  an  endothelial  protective
factor,  the  increase  in  serum  levels  causes  it  to  play  a  pro-
oxidant  role,  as  its  formation  pathway  through  xanthine
oxidase  produces  reactive  oxygen  species  and  hydrogen  per-
oxide,  which,  in  excess,  will  react  with  the  endothelial
nitric  oxide  and  create  peroxynitrite,  an  important  oxidizing
agent.27
Even  though  the  observed  mean  serum  uric  acid  level  in
our  study  was  signiﬁcantly  higher  in  the  obese  group,  when
compared  with  controls,  there  is  no  consensus  in  the  lit-
erature  on  the  reference  values  of  this  marker  in  children
and  adolescents,  which  prevents  comparisons.  However,  we
believe  that  the  serum  uric  acid  level  is  a  good  alternative  to
assess  cardiometabolic  risk  even  at  a  young  age,  as  it  can  be
seen  in  our  results.  For  this  purpose,  it  becomes  necessary
to  carry  out  studies  aimed  at  establishing  reference  values
to  help  in  clinical  diagnosis.
This  study  has  some  limitations  and,  among  them,  we
indicate  the  use  of  HOMA-IR  to  assess  insulin  resistance.  This
indicator,  although  it  is  not  the  gold  standard,  is  a  widely
used  method  because  of  its  viability.  The  absence  of  puber-
tal  status  assessment  is  another  limitation,  considering  the
age  range  used  (8--18  years).  The  cross-sectional  nature  of
the  study  does  not  allow  us  to  establish  a  causal  association
between  the  variables.
Based  on  the  observed  results,  it  can  be  concluded  that
the  increase  in  serum  uric  acid  levels  has  a  positive  statis-
tical  correlation  with  insulin  resistance  and  it  is  associated
with  the  risk  increase  of  this  resistance  in  obese  children
and  adolescents.
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